ORPHELIA Pharma will be present in Berlin on November, 6th to 8th, for the annual BIO-Europe Congress. This event is the Europe’s largest partnering conference serving the global biotechnology industry. Do not hesitate to contact us in order to meet at this occasion.
More info at: http://www.ebdgroup.com/bes/index.php
ORPHELIA Pharma will be present in Frankfurt on October 24th to 25th, 2017, in the number one Pharma event that brings together most international pharmaceuticals companies. Do not hesitate to contact us to meet at this occasion.
More info at: http://www.cphi.com/europe/
ORPHELIA Pharma will be present in Barcelona on October 4th to 6th, 2016, in the number one Pharma event that brings together most international pharmaceuticals companies. Do not hesitate to contact us to meet at this occasion.
More info at: http://www.cphi.com/europe/
ORPHELIA Pharma will be present in San Francisco on June, 6 to 9, for the BIO International Convention. The BIO International Convention attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. Do not hesitate to contact us in order to meet at this occasion.
More info at: http://convention.bio.org/
ORPHELIA Pharma will be present in Stockholm on April, 4 to 6, for the annual BIO-Europe Congress. This event is the Europe’s largest partnering conference serving the global biotechnology industry. Do not hesitate to contact us in order to meet at this occasion.
More info at: http://www.ebdgroup.com/bes/index.php
ORPHELIA Pharma joins MEDICEN Paris Région as an active member. The competitive cluster MEDICEN Paris Région, which is dedicated to new technologies and innovative therapies, and of SMEs, contributes since its creation in 2006 to boost growth and influence of the Ile-de-France health sector.
Please consult: http://www.medicen.org/
ORPHELIA Pharma, a French company specialized in the development and commercialization of pediatric medicines, today announced that initiative Octalfa joined the company as a minority shareholder, director and operating partner.
Continue readingTargeOn SAS, a French company specialized in the development and commercialization of pediatric medicines, today announced that the company will be renamed ORPHELIA Pharma SA, effective October 9th, 2015.
Continue readingORPHELIA Pharma will be present in Munich on November, 2 to 4 for the 21st annual BIO-Europe Congress. This event is the Europe’s largest partnering conference serving the global biotechnology industry. Do not hesitate to contact us to meet at this occasion.
More info at: http://www.ebdgroup.com/bioeurope/index.php and http://www.partneringone.com
Visit us at: https://www.orphelia-pharma.eu
ORPHELIA Pharma will be present in Montpellier on November 26th and 27th for the RARE congress. This event brings together manufacturers, researchers, clinicians, patient organizations, regulatory authorities, and investors involved in the field of rare diseases. Do not hesitate to contact us to meet at this occasion.
More info at: http://www.rare2015.com
Visit us at: https://www.orphelia-pharma.eu
ORPHELIA Pharma will be present in Madrid on October 13th and 14th, 2015, in the number one Pharma event that brings together most international pharmaceuticals companies. Do not hesitate to contact us to meet at this occasion.
More info at: http://www.cphi.com/europe/home
Visit us at: https://www.orphelia-pharma.eu